Laboratory Automation Market size was accounted at USD 5529.2 million in 2020, and is expected to reach USD 10281.9 million by 2030, registering a CAGR of 6.4%.Lab automation is total automation system in lab to perform the high respective task. It consolidate control of different analytical instrument, with small number of operators that reducing the cost of laboratory testing. These robotic products or lab automation are offered in modified form, according to the need of specific researcher or laboratories. Lab automation becomes vital in laboratories for handling high volumes of sample at faster rate by offering smooth solution to lab procedures such as centrifugation, decapping, aliquoting, sorting and recapping among others.
Market Segmentation:
On the basis of product, global lab automation market is categorised into equipment, and software and laboratory information. On the basis of application, the market is segmented into drug discovery, genomic solution, clinical diagnostics, and proteomic solutions. On the basis of end user, the market is divided into research institute, biotechnology & pharmaceutical industry, and other industries. On geography basis, the lab automation market is classified into North America, Europe, Asia Pacific, and RoW.
Market Dynamics and Factors:
Rise in hospital with advanced laboratory system, improvement in healthcare, advanced medical facilities, rise in R&D sector are the main drivers of the lab automation market. Moreover, growing drugs development, and pharmaceutical infrastructure help market to grow. Advantages of lab automation are high productivity and low regent cost, accuracy, and reproducibility. Further, these benefits are also raving up the demand of lab automation in various sectors. Additionally, increase in the aging population along with growing number of diagnostic test performed in laboratories is boosting the lab automation market. Higher cost of laboratory automation system may hamper the lab automation market growth. Growing awareness about laboratory automation and leading manufactures expanding their presence has opportunity to grow market in future.
Geographic Analysis:
North America dominating the global lab automation market on basis of revenue, as the large share of the market comes from that region. Growing clinical laboratory function, drugs development, and presence of developed pharmaceutical and R&D laboratories are the main factor to growth market in this region. Asia Pacific leading the market on volume basis, as rise in R&D expenditure in the region. Increasing awareness about laboratory automation, and growing pharmaceutical industries in this region help the lab automation market to grow. The market in Europe and Latin America grow with steady growth, as increasing gap between viability of train laboratory persons, and demand for laboratory procedure.
Competitive Scenario:
Some of the key player operating the global lab automation market are Hamilton Robotics, BioMerieux SA, Danaher (Beckman Coulter & Molecular devices), Tecan Group Ltd, Danahar Corporation, PerkinElmer Inc., Thermo Fisher Scientifics Inc., BMG Labtech GmbH, F. Hoffmann-La Roche AG, Aurora Biomed Inc., Hudson and Robotics, Siemen Healthcare, Roche Diagnostics, Qiagen N.V., Agilents Technologies Inc., Bio Tek Instruments Inc., and Eppendorf and Qiagen.
Lab Automation Market Report Scope
Report Attribute | Details |
Analysis Period | 2020–2030 |
Base Year | 2021 |
Forecast Period | 2022–2030 |
Market Size Estimation | Million (USD) |
Growth Rate (CAGR%) | 6.4 % |
| By Product Type (Equipment and Software & Laboratory Informatics), By Application (Drug Discovery, Clinical Diagnostics, Genomics Solutions, and Proteomics Solutions), By End User (Biotechnology & Pharmaceutical Industries, Research Institutes, and Others) |
Geographical Segmentation | North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), South America (Brazil, Argentina, Rest of SA), MEA (UAE, Saudi Arabia, South Africa) |
Key Companies Profiled | Hamilton Robotics, BioMerieux SA, Danaher (Beckman Coulter & Molecular devices), Tecan Group Ltd, Danahar Corporation, PerkinElmer Inc., Thermo Fisher Scientifics Inc., BMG Labtech GmbH, F. Hoffmann-La Roche AG, Aurora Biomed Inc., Hudson and Robotics, Siemen Healthcare, Roche Diagnostics, Qiagen N.V., Agilents Technologies Inc., Bio Tek Instruments Inc., and Eppendorf and Qiagen. |